157 related articles for article (PubMed ID: 35031902)
1. Comprehensive immunohistochemical analysis of RET, BCAR1, and BCAR3 expression in patients with Luminal A and B breast cancer subtypes.
Pavanelli AC; Mangone FR; Yoganathan P; Bessa SA; Nonogaki S; de Toledo Osório CAB; de Andrade VP; Soares IC; de Mello ES; Mulligan LM; Nagai MA
Breast Cancer Res Treat; 2022 Feb; 192(1):43-52. PubMed ID: 35031902
[TBL] [Abstract][Full Text] [Related]
2. Association of the breast cancer antiestrogen resistance protein 1 (BCAR1) and BCAR3 scaffolding proteins in cell signaling and antiestrogen resistance.
Wallez Y; Riedl SJ; Pasquale EB
J Biol Chem; 2014 Apr; 289(15):10431-10444. PubMed ID: 24584939
[TBL] [Abstract][Full Text] [Related]
3. AND-34/BCAR3 differs from other NSP homologs in induction of anti-estrogen resistance, cyclin D1 promoter activation and altered breast cancer cell morphology.
Near RI; Zhang Y; Makkinje A; Vanden Borre P; Lerner A
J Cell Physiol; 2007 Sep; 212(3):655-65. PubMed ID: 17427198
[TBL] [Abstract][Full Text] [Related]
4. Breast cancer oestrogen independence mediated by BCAR1 or BCAR3 genes is transmitted through mechanisms distinct from the oestrogen receptor signalling pathway or the epidermal growth factor receptor signalling pathway.
Dorssers LC; van Agthoven T; Brinkman A; Veldscholte J; Smid M; Dechering KJ
Breast Cancer Res; 2005; 7(1):R82-92. PubMed ID: 15642172
[TBL] [Abstract][Full Text] [Related]
5. Breast cancer anti-estrogen resistance 3 inhibits transforming growth factor β/Smad signaling and associates with favorable breast cancer disease outcomes.
Guo J; Canaff L; Rajadurai CV; Fils-Aimé N; Tian J; Dai M; Korah J; Villatoro M; Park M; Ali S; Lebrun JJ
Breast Cancer Res; 2014 Dec; 16(6):476. PubMed ID: 25499443
[TBL] [Abstract][Full Text] [Related]
6. Expression pattern of bcar3, a downstream target of Gata2, and its binding partner, bcar1, during Xenopus development.
Green YS; Kwon S; Christian JL
Gene Expr Patterns; 2016 Jan; 20(1):55-62. PubMed ID: 26631802
[TBL] [Abstract][Full Text] [Related]
7. Expression of RET is associated with Oestrogen receptor expression but lacks prognostic significance in breast cancer.
Mechera R; Soysal SD; Piscuoglio S; Ng CKY; Zeindler J; Mujagic E; Däster S; Glauser P; Hoffmann H; Kilic E; Droeser RA; Weber WP; Muenst S
BMC Cancer; 2019 Jan; 19(1):41. PubMed ID: 30621641
[TBL] [Abstract][Full Text] [Related]
8. AND-34/BCAR3, a GDP exchange factor whose overexpression confers antiestrogen resistance, activates Rac, PAK1, and the cyclin D1 promoter.
Cai D; Iyer A; Felekkis KN; Near RI; Luo Z; Chernoff J; Albanese C; Pestell RG; Lerner A
Cancer Res; 2003 Oct; 63(20):6802-8. PubMed ID: 14583477
[TBL] [Abstract][Full Text] [Related]
9. Prediction and prognostic significance of BCAR3 expression in patients with multiple myeloma.
Zhang W; Lin Y; Liu X; He X; Zhang Y; Fu W; Yang Z; Yang P; Wang J; Hu K; Zhang X; Liu W; Yuan X; Jing H
J Transl Med; 2018 Dec; 16(1):363. PubMed ID: 30563570
[TBL] [Abstract][Full Text] [Related]
10. High Expression of BCAR1 by Circulating Tumor Cells and Tumor Tissues Is Predictive of a Poor Prognosis of Early-Stage Lung Adenocarcinoma Potentially Due to Regulation of Epithelial-Mesenchymal Transition.
Jiang S; Mao C; Jiang B; Tan Q; Deng B
Technol Cancer Res Treat; 2020; 19():1533033820983086. PubMed ID: 33334252
[TBL] [Abstract][Full Text] [Related]
11. Breast cancer anti-estrogen resistance protein 1 (BCAR1/p130cas) in pulmonary disease tissue and serum.
Deng B; Huang W; Tan QY; Fan XQ; Jiang YG; Liu L; Zhong YY; Liang YG; Wang RW
Mol Diagn Ther; 2011 Feb; 15(1):31-40. PubMed ID: 21469768
[TBL] [Abstract][Full Text] [Related]
12. Bcar1/p130Cas protein and primary breast cancer: prognosis and response to tamoxifen treatment.
van der Flier S; Brinkman A; Look MP; Kok EM; Meijer-van Gelder ME; Klijn JG; Dorssers LC; Foekens JA
J Natl Cancer Inst; 2000 Jan; 92(2):120-7. PubMed ID: 10639513
[TBL] [Abstract][Full Text] [Related]
13. A Cas-BCAR3 co-regulatory circuit controls lamellipodia dynamics.
Steenkiste EM; Berndt JD; Pilling C; Simpkins C; Cooper JA
Elife; 2021 Jun; 10():. PubMed ID: 34169835
[TBL] [Abstract][Full Text] [Related]
14. The substrate domain of BCAR1 is essential for anti-estrogen-resistant proliferation of human breast cancer cells.
Brinkman A; de Jong D; Tuinman S; Azaouagh N; van Agthoven T; Dorssers LC
Breast Cancer Res Treat; 2010 Apr; 120(2):401-8. PubMed ID: 19412734
[TBL] [Abstract][Full Text] [Related]
15. Breast cancer antiestrogen resistance-3 expression regulates breast cancer cell migration through promotion of p130Cas membrane localization and membrane ruffling.
Schrecengost RS; Riggins RB; Thomas KS; Guerrero MS; Bouton AH
Cancer Res; 2007 Jul; 67(13):6174-82. PubMed ID: 17616674
[TBL] [Abstract][Full Text] [Related]
16. Breast cancer antiestrogen resistance 3-p130
Cross AM; Wilson AL; Guerrero MS; Thomas KS; Bachir AI; Kubow KE; Horwitz AR; Bouton AH
Oncogene; 2016 Nov; 35(45):5850-5859. PubMed ID: 27109104
[TBL] [Abstract][Full Text] [Related]
17. AND-34/BCAR3 regulates adhesion-dependent p130Cas serine phosphorylation and breast cancer cell growth pattern.
Makkinje A; Near RI; Infusini G; Vanden Borre P; Bloom A; Cai D; Costello CE; Lerner A
Cell Signal; 2009 Sep; 21(9):1423-35. PubMed ID: 19454314
[TBL] [Abstract][Full Text] [Related]
18. High BCAR1 expression is associated with early PSA recurrence in ERG negative prostate cancer.
Heumann A; Heinemann N; Hube-Magg C; Lang DS; Grupp K; Kluth M; Minner S; Möller-Koop C; Graefen M; Heinzer H; Tsourlakis MC; Wilczak W; Wittmer C; Jacobsen F; Huland H; Simon R; Schlomm T; Sauter G; Steurer S; Lebok P; Hinsch A
BMC Cancer; 2018 Jan; 18(1):37. PubMed ID: 29304771
[TBL] [Abstract][Full Text] [Related]
19. Expression of breast cancer anti-estrogen resistance 1 in relation to vascular endothelial growth factor, p53, and prognosis in esophageal squamous cell cancer.
Huang W; Deng B; Wang RW; Tan QY; Jiang YG
Dis Esophagus; 2013 Jul; 26(5):528-37. PubMed ID: 22816673
[TBL] [Abstract][Full Text] [Related]
20. BCAR3/AND-34 can signal independent of complex formation with CAS family members or the presence of p130Cas.
Vanden Borre P; Near RI; Makkinje A; Mostoslavsky G; Lerner A
Cell Signal; 2011 Jun; 23(6):1030-40. PubMed ID: 21262352
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
